pyrazolanthrone has been researched along with staurosporine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atteridge, CE; Azimioara, MD; Benedetti, MG; Biggs, WH; Carter, TA; Ciceri, P; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Galvin, M; Gerlach, JL; Grotzfeld, RM; Herrgard, S; Insko, DE; Insko, MA; Lai, AG; Lélias, JM; Lockhart, DJ; Mehta, SA; Milanov, ZV; Patel, HK; Treiber, DK; Velasco, AM; Wodicka, LM; Zarrinkar, PP | 1 |
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Anderson, E; Boardman, PE; Bryk, R; Chao, P; Cole, JL; Conn, GL; Duffy, NP; Griffin, JH; Nathan, C; Raimundo, BC; Wu, K | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Bowden, GT; Zhang, Y; Zhu, M | 1 |
| Fukumori, S; Hashimoto, Y; Murata, T; Taguchi, M | 1 |
| Hou, Q | 1 |
| Chae, SS; Jo, C; Jo, SA; Koh, YH; Yoo, CB; Yun, SM | 1 |
| Hasegawa, Y; Okada, Y; Shimizu, T; Takahashi, N | 1 |
| Ande, A; Jin, M; Kumar, A; Kumar, S | 1 |
10 other study(ies) available for pyrazolanthrone and staurosporine
| Article | Year |
|---|---|
A small molecule-kinase interaction map for clinical kinase inhibitors.
Topics: Benzamides; Drug Design; Escherichia coli; Escherichia coli Proteins; Imatinib Mesylate; Microchemistry; Pharmaceutical Preparations; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Pyrimidines | 2005 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Identification of new inhibitors of protein kinase R guided by statistical modeling.
Topics: Animals; Computer Simulation; Dose-Response Relationship, Drug; eIF-2 Kinase; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Macrophages; Mice; Models, Statistical; Molecular Structure; Small Molecule Libraries | 2011 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Involvement of mitogen-activated protein kinases and protein kinase C in regulation of antioxidant response element activity in human keratinocytes.
Topics: Acetophenones; Anthracenes; Antioxidants; Benzopyrans; Cells, Cultured; Enzyme Inhibitors; Green Fluorescent Proteins; Humans; Hydroquinones; Imidazoles; JNK Mitogen-Activated Protein Kinases; Keratinocytes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Pyridines; Response Elements; Rhodamines; Signal Transduction; Staurosporine; Ultraviolet Rays | 2006 |
Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells.
Topics: Anthracenes; Calcitriol; Cell Line; Curcumin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Humans; Hydroxylation; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; Lithocholic Acid; Molecular Structure; Protein Kinase Inhibitors; Receptors, Calcitriol; RNA, Messenger; Staurosporine; Time Factors; Vitamin D | 2007 |
[Effect of staurosporine induced apoptosis of MCF7/GFP-Bax stable cell line on Bax translocation from cytosol into mitochondria].
Topics: Anthracenes; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cytochromes c; Cytosol; Humans; MAP Kinase Kinase 4; Membrane Potentials; Mitochondria; Protein Transport; Staurosporine | 2008 |
Caspases-2 and -8 are involved in the presenilin1/gamma-secretase-dependent cleavage of amyloid precursor protein after the induction of apoptosis.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Anthracenes; Apoptosis; Caspase 2; Caspase 8; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Mutation; Oligopeptides; Presenilin-1; Protease Nexins; Receptors, Cell Surface; RNA, Small Interfering; Staurosporine; Transfection | 2010 |
The apoptotic volume decrease is an upstream event of MAP kinase activation during Staurosporine-induced apoptosis in HeLa cells.
Topics: Anthracenes; Apoptosis; Caspase 3; Caspase 7; Cell Size; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; MAP Kinase Kinase 4; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Pyridines; Staurosporine | 2012 |
Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway.
Topics: Allyl Compounds; Anthracenes; Apoptosis; Astrocytes; Cell Line, Tumor; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Ethanol; Gene Expression Regulation; Humans; MAP Kinase Kinase 4; Monocytes; Oxidative Stress; Plicamycin; Protein Kinase C; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Sp1 Transcription Factor; Staurosporine; Sulfides | 2013 |